Joseph E. Rittiner - Concepedia

Author

Joseph E. Rittiner

University of North Carolina at Chapel Hill ORCID

Also Known As

Coutinho-Budd, Jaeda C., Joseph E Rittiner, Joseph E. Rittiner, Joseph Edward Rittiner, Joseph Rittiner, Joseph E. Rittiner, Korboukh, Ilia, Paine, Tracie A., Pleil, Kristen E., Randhawa, Amarjit S.

Publications

946

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Duke University Harvard University National Institutes of Health

About

Joseph E. Rittiner is an author at University of North Carolina at Chapel Hill specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	701
2	Social Sciences	2	2	487
3	Anesthesia	1	1	101
4	Biochemistry	1	1	126
5	Cellular Physiology	1	1	126

Joseph E. Rittiner

Publications

902

Citations

H-Index

Page 1

	Year	Citations
A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior Eyal Vardy, J. Elliott Robinson, Chia Li, Neuron Behavioral NeuroscienceMedicineFunctional SelectivityMechanism Of ActionPsychopharmacology	2015	386
AMP Is an Adenosine A1 Receptor Agonist Joseph E. Rittiner, Ilia Korboukh, Emily A. Hull-Ryde, Journal of Biological Chemistry Adenosine Receptor ActivationSignal TransductionMolecular PhysiologyBiochemistryG Protein-coupled Receptor	2012	126
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats Christina L. Nemeth, Tracie A. Paine, Joseph E. Rittiner, Psychopharmacology Salvinorin APsychoactive DrugBehavioral NeuroscienceAddictionMedicine	2010	101
Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for Dystonia Joseph E. Rittiner, Zachary F. Caffall, Ricardo Hernández, Neuron Generalizable MechanismNeurodegenerative DiseasesMendelian DisorderDisease MechanismGenetics	2016	88
Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice Ashley Helseth, Ricardo Hernández, Victoria L. Hall, Science	2021	60
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases Joseph E. Rittiner, Malik Moncalvo, Ornit Chiba‐Falek, Frontiers in Molecular Neuroscience	2020	48
Orally Active Adenosine A<sub>1</sub>Receptor Agonists with Antinociceptive Effects in Mice Ilia Korboukh, Emily A. Hull-Ryde, Joseph E. Rittiner, Journal of Medicinal Chemistry	2012	25
The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia Zachary F. Caffall, Bradley J. Wilkes, Ricardo Hernández, Science Translational Medicine	2021	24
The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders Boris Kantor, Bernadette O’Donovan, Joseph E. Rittiner, Nature Communications	2024	21
Overexpression of Diacylglycerol Kinase η Enhances Gαq-Coupled G Protein–Coupled Receptor Signaling Joseph E. Rittiner, Victoria E. Brings, Mark J. Zylka Molecular Pharmacology	2014	13

Page 1